Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3–5 years and can persist into adulthood.
Corpus callosotomy is a surgical procedure used for treating refractory generalized seizures caused due to Lennox-Gastaut syndrome (LGS). However, this surgical procedure involves craniotomy with microdissection. Therefore, companies are focusing on the development of minimally invasive procedures such as MR-guided laser interstitial thermal therapy (MRg-LITT). MRg-LITT has emerged as a safe, effective, and durable alternative of traditional open corpus callosotomy. The efficacy of MRg-LITT is also being tested in advanced surgical ablation of epileptogenic foci and corpus callosotomy. This will further boost its adoption in LGS treatment. Such advancements in surgical treatments will be one of the key trends that will impact LGS market growth in the coming years.
Market Analysis and Insights: Global Lennox-Gastaut Syndrome Treatment Market
The research report studies the Lennox-Gastaut Syndrome Treatment market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Lennox-Gastaut Syndrome Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Lennox-Gastaut Syndrome Treatment Scope and Segment
The global Lennox-Gastaut Syndrome Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lennox-Gastaut Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Type, the market is primarily split into
Non-surgical Treatment
Surgical Treatment
by Application, this report covers the following segments
Seizures
Ocular Abnormality
EEG Findings
Others
Global Lennox-Gastaut Syndrome Treatment market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Lennox-Gastaut Syndrome Treatment key players in this market include:
Eisai Co., Ltd.
GlaxoSmithKline plc.
H. Lundbeck A/S
Johnson & Johnson Services, Inc.
Supernus Pharmaceuticals, Inc
Corpus callosotomy is a surgical procedure used for treating refractory generalized seizures caused due to Lennox-Gastaut syndrome (LGS). However, this surgical procedure involves craniotomy with microdissection. Therefore, companies are focusing on the development of minimally invasive procedures such as MR-guided laser interstitial thermal therapy (MRg-LITT). MRg-LITT has emerged as a safe, effective, and durable alternative of traditional open corpus callosotomy. The efficacy of MRg-LITT is also being tested in advanced surgical ablation of epileptogenic foci and corpus callosotomy. This will further boost its adoption in LGS treatment. Such advancements in surgical treatments will be one of the key trends that will impact LGS market growth in the coming years.
Market Analysis and Insights: Global Lennox-Gastaut Syndrome Treatment Market
The research report studies the Lennox-Gastaut Syndrome Treatment market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Lennox-Gastaut Syndrome Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Lennox-Gastaut Syndrome Treatment Scope and Segment
The global Lennox-Gastaut Syndrome Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lennox-Gastaut Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Type, the market is primarily split into
Non-surgical Treatment
Surgical Treatment
by Application, this report covers the following segments
Seizures
Ocular Abnormality
EEG Findings
Others
Global Lennox-Gastaut Syndrome Treatment market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Lennox-Gastaut Syndrome Treatment key players in this market include:
Eisai Co., Ltd.
GlaxoSmithKline plc.
H. Lundbeck A/S
Johnson & Johnson Services, Inc.
Supernus Pharmaceuticals, Inc
1 Market Overview of Lennox-Gastaut Syndrome Treatment
1.1 Lennox-Gastaut Syndrome Treatment Market Overview
1.1.1 Lennox-Gastaut Syndrome Treatment Product Scope
1.1.2 Market Status and Outlook
1.2 Global Lennox-Gastaut Syndrome Treatment Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Lennox-Gastaut Syndrome Treatment Market Size by Region (2015-2026)
1.4 Global Lennox-Gastaut Syndrome Treatment Historic Market Size by Region (2015-2020)
1.5 Global Lennox-Gastaut Syndrome Treatment Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2015-2026)
1.6.1 North America Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2015-2026)
1.6.2 Europe Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2015-2026)
1.6.4 Latin America Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2015-2026)
2 Lennox-Gastaut Syndrome Treatment Market Overview by Type
2.1 Global Lennox-Gastaut Syndrome Treatment Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Lennox-Gastaut Syndrome Treatment Historic Market Size by Type (2015-2020)
2.3 Global Lennox-Gastaut Syndrome Treatment Forecasted Market Size by Type (2021-2026)
2.4 Non-surgical Treatment
2.5 Surgical Treatment
3 Lennox-Gastaut Syndrome Treatment Market Overview by Application
3.1 Global Lennox-Gastaut Syndrome Treatment Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Lennox-Gastaut Syndrome Treatment Historic Market Size by Application (2015-2020)
3.3 Global Lennox-Gastaut Syndrome Treatment Forecasted Market Size by Application (2021-2026)
3.4 Seizures
3.5 Ocular Abnormality
3.6 EEG Findings
3.7 Others
4 Global Lennox-Gastaut Syndrome Treatment Competition Analysis by Players
4.1 Global Lennox-Gastaut Syndrome Treatment Market Size by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lennox-Gastaut Syndrome Treatment as of 2019)
4.3 Date of Key Manufacturers Enter into Lennox-Gastaut Syndrome Treatment Market
4.4 Global Top Players Lennox-Gastaut Syndrome Treatment Headquarters and Area Served
4.5 Key Players Lennox-Gastaut Syndrome Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Lennox-Gastaut Syndrome Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Eisai Co., Ltd.
5.1.1 Eisai Co., Ltd. Profile
5.1.2 Eisai Co., Ltd. Main Business
5.1.3 Eisai Co., Ltd. Lennox-Gastaut Syndrome Treatment Products, Services and Solutions
5.1.4 Eisai Co., Ltd. Lennox-Gastaut Syndrome Treatment Revenue (US$ Million) & (2015-2020)
5.1.5 Eisai Co., Ltd. Recent Developments
5.2 GlaxoSmithKline plc.
5.2.1 GlaxoSmithKline plc. Profile
5.2.2 GlaxoSmithKline plc. Main Business
5.2.3 GlaxoSmithKline plc. Lennox-Gastaut Syndrome Treatment Products, Services and Solutions
5.2.4 GlaxoSmithKline plc. Lennox-Gastaut Syndrome Treatment Revenue (US$ Million) & (2015-2020)
5.2.5 GlaxoSmithKline plc. Recent Developments
5.3 H. Lundbeck A/S
5.5.1 H. Lundbeck A/S Profile
5.3.2 H. Lundbeck A/S Main Business
5.3.3 H. Lundbeck A/S Lennox-Gastaut Syndrome Treatment Products, Services and Solutions
5.3.4 H. Lundbeck A/S Lennox-Gastaut Syndrome Treatment Revenue (US$ Million) & (2015-2020)
5.3.5 Johnson & Johnson Services, Inc. Recent Developments
5.4 Johnson & Johnson Services, Inc.
5.4.1 Johnson & Johnson Services, Inc. Profile
5.4.2 Johnson & Johnson Services, Inc. Main Business
5.4.3 Johnson & Johnson Services, Inc. Lennox-Gastaut Syndrome Treatment Products, Services and Solutions
5.4.4 Johnson & Johnson Services, Inc. Lennox-Gastaut Syndrome Treatment Revenue (US$ Million) & (2015-2020)
5.4.5 Johnson & Johnson Services, Inc. Recent Developments
5.5 Supernus Pharmaceuticals, Inc
5.5.1 Supernus Pharmaceuticals, Inc Profile
5.5.2 Supernus Pharmaceuticals, Inc Main Business
5.5.3 Supernus Pharmaceuticals, Inc Lennox-Gastaut Syndrome Treatment Products, Services and Solutions
5.5.4 Supernus Pharmaceuticals, Inc Lennox-Gastaut Syndrome Treatment Revenue (US$ Million) & (2015-2020)
5.5.5 Supernus Pharmaceuticals, Inc Recent Developments
...
6 North America
6.1 North America Lennox-Gastaut Syndrome Treatment Market Size by Country
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Lennox-Gastaut Syndrome Treatment Market Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Lennox-Gastaut Syndrome Treatment Market Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Lennox-Gastaut Syndrome Treatment Market Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
1.1 Lennox-Gastaut Syndrome Treatment Market Overview
1.1.1 Lennox-Gastaut Syndrome Treatment Product Scope
1.1.2 Market Status and Outlook
1.2 Global Lennox-Gastaut Syndrome Treatment Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Lennox-Gastaut Syndrome Treatment Market Size by Region (2015-2026)
1.4 Global Lennox-Gastaut Syndrome Treatment Historic Market Size by Region (2015-2020)
1.5 Global Lennox-Gastaut Syndrome Treatment Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2015-2026)
1.6.1 North America Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2015-2026)
1.6.2 Europe Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2015-2026)
1.6.4 Latin America Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2015-2026)
2 Lennox-Gastaut Syndrome Treatment Market Overview by Type
2.1 Global Lennox-Gastaut Syndrome Treatment Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Lennox-Gastaut Syndrome Treatment Historic Market Size by Type (2015-2020)
2.3 Global Lennox-Gastaut Syndrome Treatment Forecasted Market Size by Type (2021-2026)
2.4 Non-surgical Treatment
2.5 Surgical Treatment
3 Lennox-Gastaut Syndrome Treatment Market Overview by Application
3.1 Global Lennox-Gastaut Syndrome Treatment Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Lennox-Gastaut Syndrome Treatment Historic Market Size by Application (2015-2020)
3.3 Global Lennox-Gastaut Syndrome Treatment Forecasted Market Size by Application (2021-2026)
3.4 Seizures
3.5 Ocular Abnormality
3.6 EEG Findings
3.7 Others
4 Global Lennox-Gastaut Syndrome Treatment Competition Analysis by Players
4.1 Global Lennox-Gastaut Syndrome Treatment Market Size by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lennox-Gastaut Syndrome Treatment as of 2019)
4.3 Date of Key Manufacturers Enter into Lennox-Gastaut Syndrome Treatment Market
4.4 Global Top Players Lennox-Gastaut Syndrome Treatment Headquarters and Area Served
4.5 Key Players Lennox-Gastaut Syndrome Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Lennox-Gastaut Syndrome Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Eisai Co., Ltd.
5.1.1 Eisai Co., Ltd. Profile
5.1.2 Eisai Co., Ltd. Main Business
5.1.3 Eisai Co., Ltd. Lennox-Gastaut Syndrome Treatment Products, Services and Solutions
5.1.4 Eisai Co., Ltd. Lennox-Gastaut Syndrome Treatment Revenue (US$ Million) & (2015-2020)
5.1.5 Eisai Co., Ltd. Recent Developments
5.2 GlaxoSmithKline plc.
5.2.1 GlaxoSmithKline plc. Profile
5.2.2 GlaxoSmithKline plc. Main Business
5.2.3 GlaxoSmithKline plc. Lennox-Gastaut Syndrome Treatment Products, Services and Solutions
5.2.4 GlaxoSmithKline plc. Lennox-Gastaut Syndrome Treatment Revenue (US$ Million) & (2015-2020)
5.2.5 GlaxoSmithKline plc. Recent Developments
5.3 H. Lundbeck A/S
5.5.1 H. Lundbeck A/S Profile
5.3.2 H. Lundbeck A/S Main Business
5.3.3 H. Lundbeck A/S Lennox-Gastaut Syndrome Treatment Products, Services and Solutions
5.3.4 H. Lundbeck A/S Lennox-Gastaut Syndrome Treatment Revenue (US$ Million) & (2015-2020)
5.3.5 Johnson & Johnson Services, Inc. Recent Developments
5.4 Johnson & Johnson Services, Inc.
5.4.1 Johnson & Johnson Services, Inc. Profile
5.4.2 Johnson & Johnson Services, Inc. Main Business
5.4.3 Johnson & Johnson Services, Inc. Lennox-Gastaut Syndrome Treatment Products, Services and Solutions
5.4.4 Johnson & Johnson Services, Inc. Lennox-Gastaut Syndrome Treatment Revenue (US$ Million) & (2015-2020)
5.4.5 Johnson & Johnson Services, Inc. Recent Developments
5.5 Supernus Pharmaceuticals, Inc
5.5.1 Supernus Pharmaceuticals, Inc Profile
5.5.2 Supernus Pharmaceuticals, Inc Main Business
5.5.3 Supernus Pharmaceuticals, Inc Lennox-Gastaut Syndrome Treatment Products, Services and Solutions
5.5.4 Supernus Pharmaceuticals, Inc Lennox-Gastaut Syndrome Treatment Revenue (US$ Million) & (2015-2020)
5.5.5 Supernus Pharmaceuticals, Inc Recent Developments
...
6 North America
6.1 North America Lennox-Gastaut Syndrome Treatment Market Size by Country
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Lennox-Gastaut Syndrome Treatment Market Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Lennox-Gastaut Syndrome Treatment Market Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Lennox-Gastaut Syndrome Treatment Market Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Lennox-Gastaut Syndrome Treatment Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Lennox-Gastaut Syndrome Treatment Market Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
